Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Aug;28(8):1057-1065.
doi: 10.1016/j.cmi.2022.02.039. Epub 2022 Mar 12.

Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis

Milo Gatti  1 , Matteo Rinaldi  1 , Linda Bussini  1 , Cecilia Bonazzetti  1 , Renato Pascale  1 , Zeno Pasquini  1 , Francesca Faní  1 , Mariana Nunes Pinho Guedes  2 , Anna Maria Azzini  2 , Elena Carrara  2 , Zaira R Palacios-Baena  3 , Giulia Caponcello  4 , Eduardo Reyna-Villasmil  4 , Evelina Tacconelli  2 , Jesús Rodríguez-Baño  3 , Pierluigi Viale  1 , Maddalena Giannella  5 ; ORCHESTRA study group; Infectious Diseases Unit; Department of Integrated Management of Infectious Risk; IRCCS Policlinico Sant’Orsola; Department of Medical and Surgical Sciences; University of Bologna in Bologna, Italy; Division of Infectious Diseases; Department of Diagnostics and Public Health, University of Verona in Verona, Italy; Infectious Diseases and Microbiology Unit; Hospital Universitario Virgen Macarena; Department of Medicine, University of Sevilla/Biomedicines Institute of Sevilla in Sevilla, Spain
Collaborators, Affiliations
Meta-Analysis

Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis

Milo Gatti et al. Clin Microbiol Infect. 2022 Aug.

Abstract

Background: A significant increased risk of complications and mortality in immunocompromised patients affected by COVID-19 has been described. However, the impact of COVID-19 in solid organ transplant (SOT) recipients is an issue still under debate, due to conflicting evidence that has emerged from different observational studies.

Objectives: We performed a systematic review with a meta-analysis to assess the clinical outcome in SOT recipients with COVID-19 compared with the general population.

Data sources: PubMed-MEDLINE and Scopus were independently searched until 13 October 2021.

Study eligibility criteria: Prospective or retrospective observational studies comparing clinical outcome in SOT recipients versus general populations affected by COVID-19 were included. The primary endpoint was 30-day mortality.

Participants: Participants were patients with confirmed COVID-19.

Interventions: Interventions reviewed were SOTs.

Methods: The quality of the included studies was independently assessed with the Risk of Bias in Non-randomized Studies of Interventions tool for observational studies. The meta-analysis was performed by pooling ORs retrieved from studies providing adjustment for confounders using a random-effects model with the inverse variance method. Multiple subgroups and sensitivity analyses were conducted to investigate the source of heterogeneity.

Results: A total of 3501 articles were screened, and 31 observational studies (N = 590 375; 5759 SOT recipients vs. 584 616 general population) were included in the meta-analyses. No difference in 30-day mortality rate was found in the primary analysis, including studies providing adjustment for confounders (N = 17; 3752 SOT recipients vs. 159 745 general population; OR: 1.13; 95% CI, 0.94-1.35; I2 = 33.9%). No evidence of publication bias was reported. A higher risk of intensive care unit admission (OR: 1.56; 95% CI, 1.03-2.63) and occurrence of acute kidney injury (OR: 2.50; 95% CI, 1.81-3.45) was found in SOT recipients.

Conclusions: No increased risk in mortality was found in SOT recipients affected by COVID-19 compared with the general population when adjusted for demographic and clinical features and COVID-19 severity.

Keywords: 30-Day mortality rate; COVID-19; Clinical outcome; Solid organ transplant recipients; Superinfections.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Preferred Reporting Items for Systematic Review and Meta-Analyses flow diagram for study selection.
Fig. 2
Fig. 2
Forest plot of mortality rate in solid organ transplant recipients compared with the general population for the main analysis, including only studies providing adjusted outcome data.
Supplementary Fig 1
Supplementary Fig 1
None
Supplementary Fig 2
None
Supplementary Fig 3
See this image and copyright information in PMC

References

    1. Baek M.S., Lee M.T., Kim W.Y., Choi J.C., Jung S.Y. COVID-19-related outcomes in immunocompromised patients: a nationwide study in Korea. PLoS One. 2021;16 e0257641. - PMC - PubMed
    1. Suárez-García I., Perales-Fraile I., González-García A., Muñoz-Blanco A., Manzano L., Fabregate M., et al. In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain. PLoS One. 2021;16 e0255524. - PMC - PubMed
    1. Danziger-Isakov L., Blumberg E.A., Manuel O., Sester M. Impact of COVID-19 in solid organ transplant recipients. Am J Transplant. 2021;21:925–937. - PMC - PubMed
    1. Arya A., Li M., Aburjania N., Singh P., Royer T., Moss S., et al. COVID-19 in solid organ transplantation: disease severity and clinical update. Transplant Proc. 2021;53:1227–1236. - PMC - PubMed
    1. Miarons M., Larrosa-García M., García-García S., Los-Arcos I., Moreso F., Berastegui C., et al. COVID-19 in solid organ transplantation: a matched retrospective cohort study and evaluation of immunosuppression management. Transplantation. 2021;105:138–150. - PubMed